These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1887166)

  • 1. Pertussis: an old disease in a new era.
    Woods ML
    Semin Respir Infect; 1991 Mar; 6(1):37-43. PubMed ID: 1887166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefits of using diverse animal models for studying pertussis.
    Elahi S; Holmstrom J; Gerdts V
    Trends Microbiol; 2007 Oct; 15(10):462-8. PubMed ID: 17920273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
    Tagliabue A; De Magistris MT; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S; van Furth R; Mooi FR
    Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results with a new DTP vaccine in Japan.
    Kimura M; Hikino N
    Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.
    Kapaskelis AM; Vouloumanou EK; Rafailidis PI; Hatzopoulou P; Nikita D; Falagas ME
    Respir Med; 2008 Nov; 102(11):1586-91. PubMed ID: 18684605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 15. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccines: present status.
    Christodoulides M
    Adv Biotechnol Processes; 1990; 13():169-99. PubMed ID: 2185783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pertussis. Critical revision of its physiopathology. Implications].
    Fiore D
    Pediatr Med Chir; 1996; 18(1):109-12. PubMed ID: 8685015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of pertussis.
    Anderson EL
    Semin Respir Infect; 1989 Dec; 4(4):284-92. PubMed ID: 2560581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A commentary on the pathogenesis of pertussis.
    Hewlett EL
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S94-8. PubMed ID: 10447025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.